{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:43:02Z","timestamp":1791902582243,"version":"4.3.4"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"DOI":"10.1086\/431996","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T19:00:15Z","timestamp":1129748415000},"page":"S453-S458","source":"Crossref","is-referenced-by-count":77,"title":["Plasminogen Activator Inhibitor Type 1 Gene Polymorphism and Sepsis"],"prefix":"10.1093","volume":"41","author":[{"given":"P. W. M.","family":"Hermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Hazelzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,15]]},"reference":[{"key":"key\n\t\t\t\t20171014013243_ref1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2004.04844.x","article-title":"Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance","volume":"125","author":"Horrevoets","year":"2004","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t20171014013243_ref2","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"issue":"15","key":"key\n\t\t\t\t20171014013243_ref3","first-page":"567","article-title":"Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1: implications for the mechanism of profibrinolytic action of activated protein C","volume":"276","author":"Rezaie","year":"2001","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20171014013243_ref4","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1046\/j.1432-1033.2003.03552.x","article-title":"A steady-state competition model describes the modulating effects of thrombomodulin on thrombin inhibition by plasminogen activator inhibitor-1 in the absence and presence of vitronectin","volume":"270","author":"Dekker","year":"2003","journal-title":"Eur J Biochem"},{"key":"key\n\t\t\t\t20171014013243_ref5","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1161\/01.CIR.0000033972.90653.AF","article-title":"Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential","volume":"106","author":"Brodsky","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171014013243_ref6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1006\/jmcc.2002.2117","article-title":"Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes","volume":"34","author":"Macfelda","year":"2002","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"key\n\t\t\t\t20171014013243_ref7","first-page":"739","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20171014013243_ref8","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1055\/s-0037-1613304","article-title":"Diurnal variation in PAI-1 activity predominantly confined to the 4G-allele of the PAI-1 gene","volume":"88","author":"Hoekstra","year":"2002","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref9","doi-asserted-by":"crossref","first-page":"36847","DOI":"10.1074\/jbc.C000629200","article-title":"CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression","volume":"275","author":"Maemura","year":"2000","journal-title":"J Biol Chem"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20171014013243_ref10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.CCM.0000057849.53689.65","article-title":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia","volume":"31","author":"Levi","year":"2003","journal-title":"Crit Care Med"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20171014013243_ref11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.CCM.0000057846.21303.AB","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","volume":"31","author":"Idell","year":"2003","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00001721-200007000-00006","article-title":"Systemic activation of coagulation and fibrinolysis in a porcine model of serogroup A streptococcal shock","volume":"11","author":"Saetre","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key\n\t\t\t\t20171014013243_ref13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM198905043201802","article-title":"Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects","volume":"320","author":"Suffredini","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014013243_ref14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1182\/blood.V77.9.1949.1949","article-title":"The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia","volume":"77","author":"Sakata","year":"1991","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171014013243_ref15","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1378\/chest.103.5.1536","article-title":"Time course of hemostatic abnormalities in sepsis and its relation to outcome","volume":"103","author":"Lorente","year":"1993","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014013243_ref16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00024382-199603000-00010","article-title":"Alterations in coagulation and fibrinolysis during sepsis","volume":"5","author":"Kidokoro","year":"1996","journal-title":"Shock"},{"key":"key\n\t\t\t\t20171014013243_ref17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-995821","article-title":"Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock","volume":"24","author":"Vervloet","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t20171014013243_ref18","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1055\/s-0038-1650392","article-title":"Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis","volume":"75","author":"Mesters","year":"1996","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(90)90326-8","article-title":"Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease","volume":"57","author":"Brandtzaeg","year":"1990","journal-title":"Thromb Res"},{"key":"key\n\t\t\t\t20171014013243_ref20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0038-1650688","article-title":"Age-related differences in outcome and severity of DIC in children with septic shock and purpura","volume":"76","author":"Hazelzet","year":"1996","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref21","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/infdis\/173.5.1148","article-title":"The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock","volume":"173","author":"Kornelisse","year":"1996","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171014013243_ref22","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/01.CCM.0000072121.61120.D8","article-title":"Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study","volume":"31","author":"de Kleijn","year":"2003","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","article-title":"Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk","volume":"1","author":"Juhan-Vague","year":"2003","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF03344054","article-title":"Coagulation and fibrinolysis abnormalities in obesity","volume":"25","author":"De Pergola","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t20171014013243_ref25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1079\/PNS200199","article-title":"Plasminogen activator inhibitor-1 and haemostasis in obesity","volume":"60","author":"Mutch","year":"2001","journal-title":"Proc Nutr Soc"},{"key":"key\n\t\t\t\t20171014013243_ref26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000073579","article-title":"The insulin resistance syndrome: implications for thrombosis and cardiovascular disease","volume":"32","author":"Juhan-Vague","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20171014013243_ref27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjmed.2003.08.014","article-title":"Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease","volume":"115","author":"Lyon","year":"2003","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171014013243_ref28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0895-7061(01)02273-7","article-title":"Angiotensin and vascular fibrinolytic balance","volume":"15","author":"Vaughan","year":"2002","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20171014013243_ref29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.ATV.18.4.562","article-title":"PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants","volume":"18","author":"Margaglione","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171014013243_ref30","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1164\/ajrccm.165.8.2108089","article-title":"Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion\/deletion polymorphism","volume":"165","author":"Harding","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/hc3701.096067","article-title":"Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort","volume":"104","author":"Mukamal","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171014013243_ref32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0021-9150(97)00115-9","article-title":"Plasminogen activator inhibitor-1, the acute phase response, and vitamin C","volume":"133","author":"Woodhouse","year":"1997","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171014013243_ref33","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1055\/s-0037-1614339","article-title":"Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G\/5G promoter polymorphism in the PAI-1 gene","volume":"82","author":"Vaisanen","year":"1999","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref34","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0002-9440(10)64457-4","article-title":"Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging","volume":"161","author":"Yamamoto","year":"2002","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20171014013243_ref35","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014013243_ref36","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/ki.1996.523","article-title":"Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney","volume":"50","author":"Xu","year":"1996","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171014013243_ref37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1203\/01.PDR.0000061566.63383.F4","article-title":"Plasminogen activator inhibitor-1 in patients with Kawasaki disease: diagnostic value for the prediction of coronary artery lesion and implication for a new mode of therapy","volume":"53","author":"Senzaki","year":"2003","journal-title":"Pediatr Res"},{"key":"key\n\t\t\t\t20171014013243_ref38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/153537020422900202","article-title":"Plasminogen activator inhibitor-1 in the pathogenesis of asthma","volume":"229","author":"Cho","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"key\n\t\t\t\t20171014013243_ref39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/ajplung.00312.2002","article-title":"Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury","volume":"285","author":"Prabhakaran","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key\n\t\t\t\t20171014013243_ref40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20030115","article-title":"Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions","volume":"105","author":"Aleman","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t20171014013243_ref41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/PL00000615","article-title":"The plasminogen activator system: biology and regulation","volume":"56","author":"Irigoyen","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"key\n\t\t\t\t20171014013243_ref42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.maturitas.2003.10.015","article-title":"Crosstalk between inflammation and thrombosis","volume":"47","author":"Esmon","year":"2004","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20171014013243_ref43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH03-03-0182","article-title":"Coagulopathy of sepsis","volume":"91","author":"Dempfle","year":"2004","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/cs0880587","article-title":"Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades","volume":"88","author":"Biemond","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t20171014013243_ref45","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(00)04311-7","article-title":"Plasminogen-activator-inhibitor-1 4G\/5G promoter polymorphism and prognosis of severely injured patients","volume":"357","author":"Menges","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014013243_ref46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-2001-18864","article-title":"Disseminated intravascular coagulation in trauma patients","volume":"27","author":"Gando","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"key\n\t\t\t\t20171014013243_ref47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0038-1650248","article-title":"Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome","volume":"75","author":"Gando","year":"1996","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref48","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1073\/pnas.84.23.8548","article-title":"Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis","volume":"84","author":"Klinger","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171014013243_ref49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/01.ATV.11.1.183","article-title":"Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity","volume":"11","author":"Dawson","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"key\n\t\t\t\t20171014013243_ref50","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20171014013243_ref51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(99)02220-5","article-title":"4G\/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group","volume":"354","author":"Hermans","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014013243_ref52","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(98)09376-3","article-title":"Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock","volume":"354","author":"Westendorp","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014013243_ref53","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1097\/01.CCM.0000100122.57249.5D","article-title":"Role of functional plasminogen-activator-inhibitor-1 4G\/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children","volume":"31","author":"Haralambous","year":"2003","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00024382-199407000-00005","article-title":"Effects of trauma on immune cell function: impairment of intracellular calcium signaling","volume":"2","author":"Hoyt","year":"1994","journal-title":"Shock"},{"key":"key\n\t\t\t\t20171014013243_ref55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00005373-199802000-00016","article-title":"Trauma and thermal injury: comparison of hemostatic and cytokine changes in the acute phase of injury","volume":"44","author":"Kowal-Vern","year":"1998","journal-title":"J Trauma"},{"issue":"Suppl A","key":"key\n\t\t\t\t20171014013243_ref56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/41.suppl_1.17","article-title":"The haematological manifestations of sepsis","volume":"41","author":"Mammen","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014013243_ref57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2362.1997.570614.x","article-title":"The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia","volume":"27","author":"Levi","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20171014013243_ref58","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014013243_ref59","first-page":"43","article-title":"Fibrinolytic agents: a new approach to the treatment of adult respiratory distress syndrome","volume":"11","author":"Hardaway","year":"1994","journal-title":"Adv Ther"},{"key":"key\n\t\t\t\t20171014013243_ref60","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00003246-199805000-00039","article-title":"Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans [letter]","volume":"26","author":"Zenz","year":"1998","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref61","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/01.CCM.0000133667.86429.5D","article-title":"Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: a retrospective study","volume":"32","author":"Zenz","year":"2004","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014013243_ref62","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJM200112133452413","article-title":"Endothelial protein C activation in meningococcal sepsis","volume":"345","author":"Hazelzet","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014013243_ref63","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1055\/s-0038-1649924","article-title":"Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats","volume":"74","author":"Uchiba","year":"1995","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171014013243_ref64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1568006023337727","article-title":"Inhibition of PAI-1: a new anti-thrombotic approach","volume":"2","author":"Wu","year":"2002","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/41\/Supplement_7\/S453\/20907277\/41-Supplement_7-S453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T11:02:15Z","timestamp":1586516535000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/41\/Supplement_7\/S453\/666188\/Plasminogen-Activator-Inhibitor-Type-1-Gene"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":64,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2005,11,15]]},"published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1086\/431996","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11,15]]},"published":{"date-parts":[[2005,11,15]]}}}